AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2007
Aug 10, 2007
34117_dirs_2007-08-10_cfab4d3b-aec6-456c-9743-c72caed24bf3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2007-08-08
Reporting Person: KRUSOS DENIS A (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2007-08-08 | Common Stock | M | 1000000 | $0.25 | Acquired | 2521130 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2007-08-08 | Employee Stock Option | $0.25 | M | 1000000 | Disposed | 2013-05-05 | Common Stock (1000000) | Direct |
Footnotes
F1: Amount of securities beneficially owned represents shares held by Mr. Krusos and excludes shares Mr. Krusos has the right to
acquire upon exercise of stock options pursuant to CopyTele, Inc. stock incentive plans
F2: Right-To-Buy, pursuant to the Copytele, Inc. 2003 Share Incentive Plan.
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6